All News

Gene Editing

Invetech Launches New Korus Technology to Transform Autologous Cell Therapies
8 July 2022
Invetech Launches New Korus Technology to Transform Autologous Cell Therapies
Invetech, a Global company offering
£900 Million Investment to Expand UK Bioscience Hub – in the Largest Clusters of Life Sciences Companies in Europe
7 July 2022
£900 Million Investment to Expand UK Bioscience Hub – in the Largest Clusters of Life Sciences Companies in Europe
World-leading life science park Stevenage
Key Takeaways from ASGCT 2022
25 May 2022
Key Takeaways from ASGCT 2022
Ryan Leahy summarizes his key
ASGCT: Highlights From the Program
16 May 2022
ASGCT: Highlights From the Program
Ryan Leahy summarizes what he's
POPULAR NEWS ITEMS
Image
22 September 2022

CAR-T Manufacturing Challenges and How to Overcome Them

Image
22 September 2022

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image
22 September 2022

Looking to the Future of CAR-T Cell Therapy Manufacture

Affini-T Theraputics Completes $175 Million Financing to Advance T Cell Therapies for Solid Tumors
23 March 2022
Affini-T Theraputics Completes $175 Million Financing to Advance T Cell Therapies for Solid Tumors
Biotechnology company Affini-T Theraputics has
Genetically Engineered Product Guidelines put under the FDA Microscope
22 March 2022
Genetically Engineered Product Guidelines put under the FDA Microscope
Gene edited and CAR-T cell
Oxford Biomedica Expands AAV Business into Boston
14 March 2022
Oxford Biomedica Expands AAV Business into Boston
News
Celyad Oncology’s CAR-T Phase Ib Trial put on FDA Clinical Hold in Latest Setback
9 March 2022
Celyad Oncology’s CAR-T Phase Ib Trial put on FDA Clinical Hold in Latest Setback
News
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

CAR-T Manufacturing Challenges and How to Overcome Them

Image

Lentiviral Vector Manufacture and Testing: Challenges and Solutions

Image

Looking to the Future of CAR-T Cell Therapy Manufacture